| CYSB2400217 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-08-14 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2300217 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-11-29 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2200289 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-12-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JYSB2200032 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-02-28 | | Novo Nordisk A/S | | | view |
| JYSB2200033 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-02-28 | | Novo Nordisk A/S | | | view |
| CXSS2200007 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2022-01-26 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CYSB2101240 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2021-10-27 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JYSZ2100523 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | License Renew | 2021-07-21 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
| JYSZ2100524 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | License Renew | 2021-07-21 | | Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S | | | view |
| CXSS2101010 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.4) | New Drug Application | 2021-07-13 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| JYSB2000365 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(1) | Supplementary Application | 2020-08-07 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-08-17 | view |
| JYSB2000364 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(1) | Supplementary Application | 2020-08-07 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-08-17 | view |
| CXSL1900081 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2019-08-06 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | In Review | 2019-08-05 | view |
| CXSL1700181 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-05-07 | 吉林津升制药有限公司 | Ji Lin Jin Sheng Pharmaceutical Co Ltd | Certificate Issued | 2018-09-03 | view |
| CXSL1700223 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2018-04-26 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | In Review | 2018-04-25 | view |
| JYSB1700144 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-08-21 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-09-27 | view |
| JYSB1700128 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-07-06 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-10-30 | view |
| JYSB1700129 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2017-07-06 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-10-30 | view |
| CXSL1400055 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2014-10-11 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2016-05-19 | view |
| CXSL1300079 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2013-12-11 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2016-01-14 | view |
